In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components

By Stittelaar K.J.   Boes J.   Kersten G.F.A.   Spiekstra A.   Mulder P.G.H.   de Vries P.   Roholl P.J.M.   Dalsgaard K.   van den Dobbelsteen G.   van Alphen L.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2482-2493

Elsevier

Access to resources Recommend Favorite

Detection of measles vaccine in the throat of a vaccinated child

By Morfin F.   Beguin A.   Lina B.   Thouvenot D.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1541-1543

Elsevier

Access to resources Recommend Favorite

Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998

By Khodabandeh Loo M.   Sabahi F.   Soleimanjdahi H.   Kazemnejad A.   Roustai M.H.  

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1085-1089

Springer Publishing Company

Access to resources Recommend Favorite

Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland

By Janaszek W.   Gay N.J.   Gut W.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 473-478

Elsevier

Access to resources Recommend Favorite

Cytokine production patterns and antibody response to measles vaccine

By Ovsyannikova I.G.   Reid K.C.   Jacobson R.M.   Oberg A.L.   Klee G.G.   Poland G.A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3946-3953

Elsevier

Access to resources Recommend Favorite